Coronavirus Pandemic What Are We Doing |Biomedgrid
Journal: American Journal of Biomedical Science & Research (Vol.9, No. 6)Publication Date: 2020-07-31
Authors : Jose Carlos Herrera Garcia;
Page : 452-453
Keywords : Coronavirus; Pandemic; Anticoagulation; Diabetes; Hypothyroidism;
Abstract
Since the discovery of the new pneumonia due to coronavirus in wuhan and spreading throughout the world, it has made us reflect on the state of the human being in this world, the lethality of this virus has shown us how fragile we are in the face of biological challenges, this a pandemic with more than 600,000 deaths describes the need to think about the life we lead and the way we lead it, to be on multiple treatments and to see the mortality of patients with respiratory distress who go to the emergency services in each corner of the world is to see how the pathophysiology of the virus reminds us of clot formation and rupture of the capillary alveolar membrane capable of producing severe hypoxemia that lead the patient to a state of multisystemic shock or cytokine storm that increase patient mortality.
Other Latest Articles
- Medicinal Plants and Technology for Obtaining Medicinal Forms from Their Raw Materials |Biomedgrid
- Are Off-Label Prescriptions of ACE Inhibitors a Promising Therapy for COVID-19? |Biomedgrid
- Sepiolite Enhances Biomineralization Activity of The Cementoblasts |Biomedgrid
- Synthesis, Characterization, Biological Activity, and Scanning Electron Microscopy Studies of Schiff Base Binuclear Complexes Co (II), Cu (II), Cd (II), and Pt (II) Derivative from Tolidine with Salicylaldehyde
- Synthesis, Characterization, and Effectiveness of Pyranopyrimidine Derivatives as Multi-function Additive for Lubricating Oils
Last modified: 2023-06-21 21:31:11